BALANCE SHEET
Bal Pharma Ltd.
BSE
Jun 13
103.33
-2.54 ( -2.40%)
Volume
282
Prev. Close
105.87
Open Price
105.50
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 13
103.41
-3.15 ( -2.96%)
Volume
31665
Prev. Close
106.56
Open Price
104.90
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Balance Sheet
for the last 5 years.
ISIN No
|
INE083D01012
|
Market Cap. ( ₹ in Cr. )
|
164.64
|
P/BV
|
2.39
|
Book Value ( ₹ )
|
43.21
|
BSE Code
|
524824
|
52 Week High/Low ( ₹ )
|
158/78
|
FV/ML
|
10/1
|
P/E(X)
|
22.82
|
NSE Code
|
BALPHARMAEQ
|
Book Closure
|
25/09/2024
|
EPS ( ₹ )
|
4.53
|
Div Yield (%)
|
1.16
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
No. of Equity Shares (in Lacs) | 159.21 | 158.04 | 156.90 | 148.22 | 148.22 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 15.92 | 15.80 | 15.69 | 14.82 | 14.82 |
Total Share Capital | 15.92 | 15.80 | 15.69 | 14.82 | 14.82 |
| | | | | |
Reserves and Surplus | 96.59 | 89.78 | 78.95 | 71.56 | 63.56 |
Total Reserves and Surplus | 96.59 | 89.78 | 78.95 | 71.56 | 63.56 |
Money Received Against Share Warrants | 0.00 | 0.00 | 1.39 | 0.94 | 0.94 |
Total Shareholders Funds | 112.51 | 105.58 | 96.03 | 87.32 | 79.32 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 31.40 | 36.35 | 30.52 | 27.01 | 23.93 |
Deferred Tax Liabilities [Net] | 2.41 | 3.94 | 2.86 | 2.47 | 4.40 |
Other Long Term Liabilities | 1.28 | 1.34 | 1.23 | 3.63 | 3.04 |
Long Term Provisions | 5.46 | 4.93 | 4.91 | 4.60 | 3.97 |
Total Non-Current Liabilities | 40.54 | 46.56 | 39.52 | 37.72 | 35.35 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 113.21 | 97.48 | 94.71 | 70.99 | 75.05 |
Trade Payables | 88.65 | 89.84 | 90.77 | 71.93 | 48.56 |
Other Current Liabilities | 17.02 | 20.90 | 26.05 | 20.99 | 22.62 |
Short Term Provisions | 1.15 | 0.93 | 0.63 | 0.67 | 0.65 |
Total Current Liabilities | 220.03 | 209.16 | 212.15 | 164.57 | 146.87 |
| | | | | |
Total Capital And Liabilities | 373.08 | 361.30 | 347.70 | 289.61 | 261.54 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 58.43 | 53.18 | 52.62 | 44.92 | 45.42 |
Intangible Assets | 11.99 | 11.38 | 10.45 | 7.98 | 7.23 |
Capital Work-In-Progress | 1.78 | 0.47 | 0.00 | 1.16 | 0.00 |
Fixed Assets | 72.21 | 65.03 | 63.07 | 54.06 | 52.65 |
Non-Current Investments | 9.58 | 9.58 | 8.40 | 8.40 | 8.40 |
Deferred Tax Assets [Net] | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.33 |
Other Non-Current Assets | 10.68 | 5.55 | 6.29 | 6.89 | 6.96 |
Total Non-Current Assets | 92.86 | 80.16 | 77.75 | 69.35 | 68.34 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 2.47 | 6.76 | 0.00 | 0.00 | 0.00 |
Inventories | 102.17 | 87.49 | 97.69 | 73.97 | 60.12 |
Trade Receivables | 96.10 | 103.10 | 94.84 | 77.91 | 69.44 |
Cash And Cash Equivalents | 7.92 | 13.13 | 7.35 | 5.09 | 3.72 |
Short Term Loans And Advances | 33.63 | 35.12 | 33.66 | 25.72 | 20.70 |
OtherCurrentAssets | 37.93 | 35.54 | 36.41 | 37.57 | 39.23 |
Total Current Assets | 280.22 | 281.14 | 269.95 | 220.27 | 193.20 |
| | | | | |
Total Assets | 373.08 | 361.30 | 347.70 | 289.61 | 261.54 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 0.00 | 16.96 | 16.44 | 16.25 | 4.34 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 0.00 | 3.04 | 3.04 | 3.04 | 3.04 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Quoted Market Value | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 |
Non-Current Investments Unquoted Book Value | 0.00 | 9.59 | 0.00 | 0.00 | 9.57 |